Literature DB >> 18483626

Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice.

Stephan E Lehnart1, Marco Mongillo, Andrew Bellinger, Nicolas Lindegger, Bi-Xing Chen, William Hsueh, Steven Reiken, Anetta Wronska, Liam J Drew, Chris W Ward, W J Lederer, Robert S Kass, Gregory Morley, Andrew R Marks.   

Abstract

The Ca2+ release channel ryanodine receptor 2 (RyR2) is required for excitation-contraction coupling in the heart and is also present in the brain. Mutations in RyR2 have been linked to exercise-induced sudden cardiac death (catecholaminergic polymorphic ventricular tachycardia [CPVT]). CPVT-associated RyR2 mutations result in "leaky" RyR2 channels due to the decreased binding of the calstabin2 (FKBP12.6) subunit, which stabilizes the closed state of the channel. We found that mice heterozygous for the R2474S mutation in Ryr2 (Ryr2-R2474S mice) exhibited spontaneous generalized tonic-clonic seizures (which occurred in the absence of cardiac arrhythmias), exercise-induced ventricular arrhythmias, and sudden cardiac death. Treatment with a novel RyR2-specific compound (S107) that enhances the binding of calstabin2 to the mutant Ryr2-R2474S channel inhibited the channel leak and prevented cardiac arrhythmias and raised the seizure threshold. Thus, CPVT-associated mutant leaky Ryr2-R2474S channels in the brain can cause seizures in mice, independent of cardiac arrhythmias. Based on these data, we propose that CPVT is a combined neurocardiac disorder in which leaky RyR2 channels in the brain cause epilepsy, and the same leaky channels in the heart cause exercise-induced sudden cardiac death.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18483626      PMCID: PMC2381750          DOI: 10.1172/JCI35346

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  63 in total

1.  An astrocytic basis of epilepsy.

Authors:  Guo-Feng Tian; Hooman Azmi; Takahiro Takano; Qiwu Xu; Weiguo Peng; Jane Lin; NancyAnn Oberheim; Nanhong Lou; Xiaohai Wang; H Ronald Zielke; Jian Kang; Maiken Nedergaard
Journal:  Nat Med       Date:  2005-08-14       Impact factor: 53.440

2.  Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients.

Authors:  A V Postma; I Denjoy; J Kamblock; M Alders; J-M Lupoglazoff; G Vaksmann; L Dubosq-Bidot; P Sebillon; M M A M Mannens; P Guicheney; A A M Wilde
Journal:  J Med Genet       Date:  2005-11       Impact factor: 6.318

3.  Altered seizure susceptibility in mice lacking the Ca(v)2.3 E-type Ca2+ channel.

Authors:  Marco Weiergräber; Margit Henry; Andreas Krieger; Marcel Kamp; Kayalvizhi Radhakrishnan; Jürgen Hescheler; Toni Schneider
Journal:  Epilepsia       Date:  2006-05       Impact factor: 5.864

Review 4.  The Long QT and Brugada syndromes: causes of unexpected syncope and sudden cardiac death in children and young adults.

Authors:  G Michael Vincent
Journal:  Semin Pediatr Neurol       Date:  2005-03       Impact factor: 1.636

5.  Pathogenesis of unexplained drowning: new insights from a molecular autopsy.

Authors:  David J Tester; Laura J Kopplin; Wendy Creighton; Allen P Burke; Michael J Ackerman
Journal:  Mayo Clin Proc       Date:  2005-05       Impact factor: 7.616

6.  Effects of ryanodine receptor activation on neurotransmitter release and neuronal cell death following kainic acid-induced status epilepticus.

Authors:  Fumiaki Mori; Motohiro Okada; Masahiko Tomiyama; Sunao Kaneko; Koichi Wakabayashi
Journal:  Epilepsy Res       Date:  2005-06       Impact factor: 3.045

7.  Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failure.

Authors:  Xander H T Wehrens; Stephan E Lehnart; Steven Reiken; Roel van der Nagel; Raymond Morales; Jie Sun; Zhenzhuang Cheng; Shi-Xiang Deng; Leon J de Windt; Donald W Landry; Andrew R Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-22       Impact factor: 11.205

8.  Intracellular calcium release channel expression during embryogenesis.

Authors:  N Rosemblit; M C Moschella; E Ondriašová; D E Gutstein; K Ondriaš; A R Marks
Journal:  Dev Biol       Date:  1999-02-15       Impact factor: 3.582

9.  Cardiac arrhythmias in focal epilepsy: a prospective long-term study.

Authors:  Fergus J Rugg-Gunn; Robert J Simister; Mark Squirrell; Diana R Holdright; John S Duncan
Journal:  Lancet       Date:  2004 Dec 18-31       Impact factor: 79.321

10.  Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor.

Authors:  Marina Cerrone; Barbara Colombi; Massimo Santoro; Marina Raffaele di Barletta; Mario Scelsi; Laura Villani; Carlo Napolitano; Silvia G Priori
Journal:  Circ Res       Date:  2005-05-12       Impact factor: 17.367

View more
  157 in total

1.  Revisiting the ionic mechanisms of early afterdepolarizations in cardiomyocytes: predominant by Ca waves or Ca currents?

Authors:  Zhenghang Zhao; Hairuo Wen; Nadezhda Fefelova; Charelle Allen; Akemichi Baba; Toshio Matsuda; Lai-Hua Xie
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-02-03       Impact factor: 4.733

2.  CRISPR/Cas9 Gene editing of RyR2 in human stem cell-derived cardiomyocytes provides a novel approach in investigating dysfunctional Ca2+ signaling.

Authors:  Hua Wei; Xiao-Hua Zhang; Cassandra Clift; Naohiro Yamaguchi; Martin Morad
Journal:  Cell Calcium       Date:  2018-04-27       Impact factor: 6.817

3.  Interpreting Incidentally Identified Variants in Genes Associated With Catecholaminergic Polymorphic Ventricular Tachycardia in a Large Cohort of Clinical Whole-Exome Genetic Test Referrals.

Authors:  Andrew P Landstrom; Andrew L Dailey-Schwartz; Jill A Rosenfeld; Yaping Yang; Margaret J McLean; Christina Y Miyake; Santiago O Valdes; Yuxin Fan; Hugh D Allen; Daniel J Penny; Jeffrey J Kim
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-04

4.  Role of chronic ryanodine receptor phosphorylation in heart failure and β-adrenergic receptor blockade in mice.

Authors:  Jian Shan; Matthew J Betzenhauser; Alexander Kushnir; Steven Reiken; Albano C Meli; Anetta Wronska; Miroslav Dura; Bi-Xing Chen; Andrew R Marks
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

Review 5.  Mechanisms of altered Ca²⁺ handling in heart failure.

Authors:  Min Luo; Mark E Anderson
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

6.  Novel carvedilol analogues that suppress store-overload-induced Ca2+ release.

Authors:  Chris D Smith; Aixia Wang; Kannan Vembaiyan; Jingqun Zhang; Cuihong Xie; Qiang Zhou; Guogen Wu; S R Wayne Chen; Thomas G Back
Journal:  J Med Chem       Date:  2013-11-05       Impact factor: 7.446

7.  Role of CaMKIIdelta phosphorylation of the cardiac ryanodine receptor in the force frequency relationship and heart failure.

Authors:  Alexander Kushnir; Jian Shan; Matthew J Betzenhauser; Steven Reiken; Andrew R Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

8.  Reversal of Calcium Dysregulation as Potential Approach for Treating Alzheimer's Disease.

Authors:  Elena Popugaeva; Daria Chernyuk; Ilya Bezprozvanny
Journal:  Curr Alzheimer Res       Date:  2020       Impact factor: 3.498

9.  Malformed mdx myofibers have normal cytoskeletal architecture yet altered EC coupling and stress-induced Ca2+ signaling.

Authors:  Richard M Lovering; Luke Michaelson; Christopher W Ward
Journal:  Am J Physiol Cell Physiol       Date:  2009-07-15       Impact factor: 4.249

Review 10.  Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target.

Authors:  Dobromir Dobrev
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-09-26       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.